Extrawell Pharmaceutical Holdings Limited reported earnings results for the half year ended September 30, 2023. For the half year, the company reported sales was HKD 30.14 million compared to HKD 34.1 million a year ago. Net loss was HKD 237.73 million compared to net income of HKD 45.82 million a year ago.

Basic loss per share from continuing operations was HKD 0.0995 compared to basic earnings per share from continuing operations of HKD 0.0192 a year ago. Diluted loss per share from continuing operations was HKD 0.0995 compared to diluted earnings per share from continuing operations of HKD 0.0162 a year ago.